MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 164 filers reported holding MIRATI THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.50 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,341,000 | +73.9% | 19,200 | +67.1% | 0.01% | +57.1% |
| Q2 2022 | $771,000 | +262.0% | 11,491 | +343.5% | 0.01% | +250.0% |
| Q1 2022 | $213,000 | -1.4% | 2,591 | +43.4% | 0.00% | 0.0% |
| Q4 2021 | $216,000 | -39.5% | 1,807 | -10.4% | 0.00% | 0.0% |
| Q3 2021 | $357,000 | +11.9% | 2,017 | +2.3% | 0.00% | 0.0% |
| Q2 2021 | $319,000 | -43.9% | 1,972 | -40.6% | 0.00% | -50.0% |
| Q1 2021 | $569,000 | -22.1% | 3,322 | 0.0% | 0.00% | -20.0% |
| Q4 2020 | $730,000 | +266.8% | 3,322 | +176.8% | 0.01% | +150.0% |
| Q3 2020 | $199,000 | +485.3% | 1,200 | +300.0% | 0.00% | – |
| Q2 2020 | $34,000 | +100.0% | 300 | +36.4% | 0.00% | – |
| Q1 2020 | $17,000 | -51.4% | 220 | -18.5% | 0.00% | – |
| Q4 2019 | $35,000 | +191.7% | 270 | +80.0% | 0.00% | – |
| Q3 2019 | $12,000 | -20.0% | 150 | 0.0% | 0.00% | – |
| Q2 2019 | $15,000 | +36.4% | 150 | 0.0% | 0.00% | – |
| Q1 2019 | $11,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 2,881,702 | $14,985,000 | 6.99% |
| Avoro Capital Advisors LLC | 2,383,201 | $12,393,000 | 1.58% |
| Broadfin Capital, LLC | 2,090,801 | $10,872,000 | 1.32% |
| Boxer Capital, LLC | 1,037,994 | $5,398,000 | 1.18% |
| Ghost Tree Capital, LLC | 172,184 | $895,000 | 0.17% |
| Baker Brothers Advisors | 2,269,198 | $11,800,000 | 0.10% |
| Hillhouse Capital Management | 725,000 | $3,770,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 249,735 | $1,299,000 | 0.07% |
| Rhenman & Partners Asset Management AB | 50,000 | $260,000 | 0.04% |
| Trexquant Investment LP | 42,879 | $223,000 | 0.03% |